NEW YORK (360Dx) – British diagnostics firm Oncimmune said today that it has made SmartGene the exclusive distributor of its EarlyCDT-Lung test in Poland.

Oncimmune's test measures levels of seven autoantibodies in patient blood to aid in the early detection of lung cancer. The company markets EarlyCDT-Lung both for detecting lung cancer before it can be picked up via imaging techniques and for helping to evaluate whether nodules detected via imaging are likely malignant or benign.